Next Generation pVAD
Temporary mechanical circulatory support for High-Risk Percutaneous Coronary Intervention (PCI) and Cardiogenic Shock (CS)
PivotalActive
Key Facts
Indication
Temporary mechanical circulatory support for High-Risk Percutaneous Coronary Intervention (PCI) and Cardiogenic Shock (CS)
Phase
Pivotal
Status
Active
Company
About Supira Medical
Supira Medical is advancing a novel pVAD platform aimed at addressing significant unmet needs in high-risk interventional cardiology and acute heart failure. The company has generated clinical data from 99 patients across international early feasibility studies and is preparing for a U.S. pivotal trial. With a leadership team boasting extensive experience from major medtech firms, Supira is positioning its device as a potential best-in-class solution by combining low vascular access profile with high flow rates to minimize complications and avoid device escalation.
View full company profile